Seres Therapeutics MCRB
NASDAQ MCRB
$2.09 -0.04 (-1.88%)
At close: Oct 23, 2026 · 4:00 PM EDT

Seres Therapeutics (MCRB) Non Operating Investment Income (2025 - 2026)

Updated

Seres Therapeutics' Non Operating Investment Income came in at $25 million for Q2 2026, compared with $185,000 a year earlier.

Analysis

Seres Therapeutics (MCRB) Non Operating Investment Income (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Seres Therapeutics reported Non Operating Investment Income of $27.37 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Seres Therapeutics 20.54 Mn -118.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.00 Mn
Jun 30, 2025 185,000.00
Mar 31, 2025 2.18 Mn
API Access

Seres Therapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=MCRB&period=max&api_key=YOUR_API_KEY